Claret Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.72M Sell
4,886
-14
-0.3% -$4.99K 0.21% 64
2025
Q4
$1.6M Sell
4,900
-101
-2% -$32K 0.19% 68
2025
Q3
$1.41M Sell
5,001
-429
-8% -$124K 0.17% 70
2025
Q2
$1.52M Buy
5,430
+21
+0.4% +$5.95K 0.2% 67
2025
Q1
$1.69M Buy
+5,409
New +$1.6M 0.24% 57
2021
Q4
Sell
-6,426
Closed -$1.37M 175
2021
Q3
$1.37M Buy
6,426
+207
+3% +$47.6K 0.23% 57
2021
Q2
$1.52M Hold
6,219
0.25% 56
2021
Q1
$1.55M Buy
6,219
+39
+0.6% +$9.31K 0.29% 53
2020
Q4
$1.42M Sell
6,180
-102
-2% -$23.5K 0.28% 55
2020
Q3
$1.6M Sell
6,282
-221
-3% -$54.8K 0.36% 51
2020
Q2
$1.53M Sell
6,503
-376
-5% -$85.8K 0.36% 53
2020
Q1
$1.4M Sell
6,879
-57
-0.8% -$12.4K 0.39% 53
2019
Q4
$1.67M Sell
6,936
-120
-2% -$26.5K 0.32% 57
2019
Q3
$1.36M Sell
7,056
-94
-1% -$18K 0.28% 72
2019
Q2
$1.32M Buy
7,150
+16
+0.2% +$2.87K 0.27% 67
2019
Q1
$1.35M Sell
7,134
-253
-3% -$48.3K 0.27% 71
2018
Q4
$1.44M Sell
7,387
-256
-3% -$49.9K 0.32% 65
2018
Q3
$1.58M Sell
7,643
-109
-1% -$21.5K 0.31% 66
2018
Q2
$1.43M Buy
7,752
+228
+3% +$40.3K 0.29% 69
2018
Q1
$1.28M Sell
7,524
-4
-0.1% -$734 0.29% 70
2017
Q4
$1.31M Buy
+7,528
New +$1.33M 0.29% 71

Other funds holding AMGN

Claret Asset Management's AMGN Position: Q1 2026 in Review

Claret Asset Management reduced its Amgen (AMGN) stake by 0.29% in Q1 2026, selling an estimated $4.99K and leaving 4,886 shares worth $1.72M. The position accounts for 0.21% of the portfolio, ranked #64.

Claret Asset Management first reported a position in AMGN in Q4 2017 and has held it in 21 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Claret Asset Management held 4,886 shares of Amgen worth $1.72M as of Q1 2026.
  • Claret Asset Management sold 14 Amgen shares in Q1 2026, an estimated $4.99K.
  • Amgen made up 0.21% of Claret Asset Management's portfolio in Q1 2026, its #64 holding.
  • Claret Asset Management first reported a position in Amgen in Q4 2017 and has held it in 21 quarters since.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Claret Asset Management's 13F filing for Q1 2026, filed 11 May 2026.